EN
HI
Summary
As of 12 Nov, 2026, Valiant Laboratories stock price is ₹107.1. During the trading session, the stock has moved between an intraday low of ₹107.10 and an intraday high of ₹107.10. Over the last 52 weeks, Valiant Laboratories has traded between ₹49.51 and ₹141.38.
The stock has recorded a trading volume of 3,116 shares,. Its Average Traded Price (ATP) is ₹107.10, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 200 @ ₹107.10.
Valiant Laboratories has an upper circuit limit of ₹111.46 and a lower circuit limit of ₹107.10. The total value traded stands at ₹3.34 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Valiant Laboratories also offers a dividend yield of 0%.
Valiant Laboratories Share Price Chart
Valiant Laboratories Share Key Metrics
Volume
3116.00
Market Cap
593.53 CR
LTQ@LTP
200@107.10
ATP
107.1
Var Margin
100 %
Circuit Range
107.1-111.46
Delivery %
0 %
Value
3.34 L
ASM/GSM
No
Market Lot
1
Valiant Laboratories Fundamentals
P/E Ratio
36.7
P/B Ratio
1.79
Div. Yield
0
Sector P/E
41.06
Sector P/B
3.86
Sec. Div. Yield
0.53
Valiant Laboratories Resistance and Support
Pivot 109.28
Resistance
First Resistance
109.28
Second Resistance
109.28
Third Resistance
109.28
Support
First Support
109.28
Second Support
109.28
Third Support
109.28
Valiant Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 12 2026 | 107.1 | 107.1 | -1.99% | 107.1 | 107.1 |
| Wed Nov 11 2026 | 109.27 | 109.27 | -2.01% | 109.27 | 109.27 |
| Mon Nov 09 2026 | 111.51 | 111.51 | -1.99% | 111.51 | 111.51 |
Valiant Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2025-05-20 | Audited Results |
Valiant Laboratories News
Valiant Laboratories Ltd - 543998 - Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter And Half Year Ended September 30, 2026.
Valiant Laboratories reported Q2 FY27 cons. revenue of ₹116.77 crore (up 152.7% YoY) and net profit of ₹0.41 crore (up 106.6% YoY). Standalone net profit for the quarter increased to ₹1.45 crore from ₹0.16 crore in Q2 FY26.
Nov 02 2026 19:01:28
Valiant Laboratories Ltd - 543998 - Board Meeting Intimation for Financial Results For The Quarter And Half Year Ended September 30, 2026.
Valiant Laboratories board to meet on 02 Nov 2026 for financial results.
Oct 27 2026 17:19:46
Valiant Laboratories Management
| Name | Position |
|---|---|
| Mulesh M Savla | Non Executive Independent Director |
| Santosh S Vora | Managing Director |
Valiant Laboratories Similar Stocks
Hexagon Nutrition Ltd.
59.91
-0.08 (0.13%)
Wanbury Ltd.
199.94
-4.13 (2.02%)
Kilitch Drugs (India) Ltd.
200.61
3.00 (1.52%)
Osel Devices Ltd.
387.75
2.10 (0.54%)
Kaya Ltd.
349.15
-7.10 (1.99%)
Chandan Healthcare Ltd.
236.00
-2.00 (0.84%)
Influx Healthtech Ltd.
267.95
14.05 (5.53%)
Accent Microcell Ltd.
609.35
5.45 (0.90%)
Rays Of Belief Ltd.
295.82
39.25 (15.30%)
Valiant Laboratories FAQs
The Buying Price of Valiant Laboratories share is 107.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Valiant Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Valiant Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Valiant Laboratories shares is 36.7. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Valiant Laboratories shares is 1.79. Useful to assess the stock's value relative to its book value.
To assess Valiant Laboratories’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Valiant Laboratories is 593.53 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Valiant Laboratories share price is 141.38 & 49.51. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Valiant Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in VALIANTLAB
Or Download Choice FinX App
Invest in VALIANTLAB
